Cargando…
联合社会人口学因素及临床因素预测初发慢性髓性白血病慢性期患者治疗反应及结局
OBJECTIVE: To explore the impacts of socio-demographic and clinical co-variates on treatment responses and outcomes in patients with chronic myeloid leukemia in the chronic phase (CML-CP) receiving tyrosine kinase inhibitor (TKI) and identified the predictive models for them. METHODS: Data of newly...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980668/ https://www.ncbi.nlm.nih.gov/pubmed/35231994 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.01.011 |
Ejemplares similares
-
伊马替尼治疗初发慢性髓性白血病慢性期患者获得分子学反应的临床预测模型
Publicado: (2023) -
尼洛替尼一线治疗慢性髓性白血病的疗效及影响实现分子学反应的因素分析
Publicado: (2020) -
初发慢性髓性白血病慢性期不同年龄患者临床特征、治疗和结局
Publicado: (2021) -
氟马替尼与伊马替尼治疗初发慢性髓性白血病慢性期患者的有效性及严重血液学不良反应发生率比较
Publicado: (2023) -
二代酪氨酸激酶抑制剂一线治疗慢性髓性白血病慢性期患者发生严重血细胞减少的相关因素及其对治疗反应和结局的影响
Publicado: (2023)